Short Interest in ProtoKinetix, Incorporated (OTCMKTS:PKTX) Drops By 70.7%

ProtoKinetix, Incorporated (OTCMKTS:PKTX) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 15,700 shares, a drop of 70.7% from the November 30th total of 53,500 shares. Based on an average daily trading volume, of 279,600 shares, the short-interest ratio is currently 0.1 days.

ProtoKinetix Price Performance

Shares of PKTX remained flat at $0.01 on Thursday. ProtoKinetix has a one year low of $0.01 and a one year high of $0.02. The stock has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01.

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.